XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 12,939 $ 4,562
General and administrative 3,795 3,075
Total operating expenses 16,734 7,637
Loss from operations (16,734) (7,637)
Other income net 2,080 1,111
Net loss $ (14,654) $ (6,526)
Net loss per share, basic $ (0.27) $ (0.15)
Net loss per share, diluted $ (0.27) $ (0.15)
Weighted average common shares outstanding, basic 53,553,707 43,897,603
Weighted average common shares outstanding, diluted 53,553,707 43,897,603
Comprehensive loss:    
Net loss $ (14,654) $ (6,526)
Other comprehensive gain (loss):    
Unrealized gain (loss) on marketable securities (106) 31
Total other comprehensive gain (loss) (106) 31
Total comprehensive loss $ (14,760) $ (6,495)